Related Experiment Videos

Neurological protection provided by candesartan: reviewing the latest study results

Didier Leys1

  • 1Neurological Department, University of Lille, Lille, France.

Current Medical Research and Opinion
|September 19, 2003
PubMed

Insights

Antihypertensive treatments, like candesartan, may prevent dementia and stroke in patients with high blood pressure. Candesartan shows promise due to its neuroprotective effects and ability to reduce non-fatal strokes.

Area of Science:

  • Neurology
  • Cardiovascular Medicine
  • Geriatrics

Background:

  • Arterial hypertension is a significant risk factor for stroke, cognitive decline, and dementia.
  • Previous clinical trials (Syst-Eur, PROGRESS, SCOPE) suggest antihypertensive therapy may prevent dementia.

Purpose of the Study:

  • To evaluate the potential of antihypertensive treatment, specifically candesartan, in preventing dementia and stroke.
  • To highlight the neuroprotective properties of candesartan.

Main Methods:

  • Review of clinical trial data including Syst-Eur, PROGRESS, and SCOPE findings.
  • Examination of preclinical studies on candesartan's neuroprotective effects in cerebral ischemia models.
  • Analysis of candesartan's efficacy in preventing non-fatal strokes in hypertensive elderly individuals.

Main Results:

  • Antihypertensive treatments show potential for dementia prevention.
  • Candesartan exhibits neuroprotective effects in animal models of cerebral ischemia.
  • Candesartan has demonstrated efficacy in preventing non-fatal strokes in elderly hypertensive patients.

Conclusions:

  • Antihypertensive therapy represents a viable strategy for dementia prevention.
  • Candesartan is a promising agent for both stroke prevention and cognitive protection in hypertensive individuals.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...